{"id":"https://openalex.org/W3214737010","doi":"https://doi.org/10.1183/13993003.congress-2021.pa890","title":"Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma","display_name":"Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma","alternate_titles":[],"publication_year":2021,"publication_date":"2021-09-05","ids":{"openalex":"https://openalex.org/W3214737010","doi":"https://doi.org/10.1183/13993003.congress-2021.pa890","mag":"3214737010"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2021.pa890","doi":"https://doi.org/10.1183/13993003.congress-2021.pa890","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2021.pa890","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W3214737010"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019367565","display_name":"Glenn Van Hulst","orcid":"https://orcid.org/0000-0003-3431-9127","observed_orcids":["https://orcid.org/0000-0003-3431-9127"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Glenn Van Hulst","raw_affiliation_strings":["University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024340756","display_name":"Joseph Jorssen","orcid":"https://orcid.org/0000-0001-6247-906X","observed_orcids":["https://orcid.org/0000-0001-6247-906X"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph Jorssen","raw_affiliation_strings":["University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039960852","display_name":"Nathalie Jacobs","orcid":"https://orcid.org/0000-0002-9895-8465","observed_orcids":["https://orcid.org/0000-0002-9895-8465"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nathalie Jacobs","raw_affiliation_strings":["University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085151472","display_name":"Monique A. Henket","orcid":"https://orcid.org/0000-0001-9648-9645","observed_orcids":["https://orcid.org/0000-0001-9648-9645"]},"institutions":[{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Monique Henket","raw_affiliation_strings":["CHU de Li\u00e8ge - Pneumology, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU de Li\u00e8ge - Pneumology, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I4210134544"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030456446","display_name":"Renaud E. Louis","orcid":"https://orcid.org/0000-0002-4737-9084","observed_orcids":["https://orcid.org/0000-0002-4737-9084"]},"institutions":[{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Renaud Louis","raw_affiliation_strings":["CHU de Li\u00e8ge - Pneumology, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU de Li\u00e8ge - Pneumology, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I4210134544"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022924667","display_name":"Florence Schleich","orcid":"https://orcid.org/0000-0002-2678-1373","observed_orcids":["https://orcid.org/0000-0002-2678-1373"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Florence Schleich","raw_affiliation_strings":["University of Li\u00e8ge - Department of Pulmonary Medicine, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Li\u00e8ge - Department of Pulmonary Medicine, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056092531","display_name":"Fabrice Bureau","orcid":"https://orcid.org/0000-0001-6264-4029","observed_orcids":["https://orcid.org/0000-0001-6264-4029"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fabrice Bureau","raw_affiliation_strings":["University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016810968","display_name":"Christophe J. Desmet","orcid":"https://orcid.org/0000-0002-5723-2449","observed_orcids":["https://orcid.org/0000-0002-5723-2449"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christophe Desmet","raw_affiliation_strings":["University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Li\u00e8ge - Laboratory of Cellular and Molecular Immunology, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5019367565"],"corresponding_institution_ids":["https://openalex.org/I157674565"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA890","last_page":"PA890"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12528","display_name":"IL-33, ST2, and ILC Pathways","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12538","display_name":"Eosinophilic Esophagitis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mepolizumab","display_name":"mepolizumab","score":0.9539999961853027},{"id":"https://openalex.org/keywords/anti-il-5-therapy","display_name":"anti-IL-5 therapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/eosinophilic-asthma","display_name":"eosinophilic asthma","score":0.8809999823570251},{"id":"https://openalex.org/keywords/il-5","display_name":"IL-5","score":0.8460000157356262},{"id":"https://openalex.org/keywords/il-33","display_name":"IL-33","score":0.8119999766349792},{"id":"https://openalex.org/keywords/eosinophil-activation","display_name":"eosinophil activation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/eosinophil-development","display_name":"eosinophil development","score":0.7419999837875366},{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":0.9440000057220459},{"id":"https://openalex.org/keywords/eosinophilia","display_name":"eosinophilia","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C2777832160","wikidata":"https://www.wikidata.org/wiki/Q3306175","display_name":"Mepolizumab","level":4,"score":0.8895385265350342},{"id":"https://openalex.org/C2777129736","wikidata":"https://www.wikidata.org/wiki/Q505142","display_name":"Eosinophilia","level":2,"score":0.7698965668678284},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.674724817276001},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.6630089282989502},{"id":"https://openalex.org/C181901479","wikidata":"https://www.wikidata.org/wiki/Q14877650","display_name":"Interleukin 5","level":4,"score":0.6097291111946106},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5613299012184143},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.44164055585861206},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4389500617980957},{"id":"https://openalex.org/C2777456892","wikidata":"https://www.wikidata.org/wiki/Q107988","display_name":"Basophil","level":4,"score":0.42280250787734985},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3320368528366089},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.24232712388038635},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.196351557970047},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1351151168346405},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.10670176148414612},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2021.pa890","doi":"https://doi.org/10.1183/13993003.congress-2021.pa890","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2021.pa890","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3197512360","https://openalex.org/W4410270914","https://openalex.org/W4416637816","https://openalex.org/W4404104674","https://openalex.org/W3183777853","https://openalex.org/W1974262000","https://openalex.org/W2142587628","https://openalex.org/W7204845564","https://openalex.org/W4404098289"],"abstract_inverted_index":{"Interleukin-5":[0],"(IL)-5":[1],"is":[2,60],"an":[3],"essential":[4],"driver":[5],"of":[6,32,41,63,70,83,97,127,142,160,185,207,213],"eosinophilia":[7,24],"which":[8],"correlates":[9],"with":[10,19,144,147],"disease":[11],"severity":[12],"in":[13,29,45,66,99,110,139,170,187],"severe":[14],"eosinophilic":[15],"asthma":[16],"(SEA).":[17],"Treatment":[18],"anti-IL5":[20,49],"biological":[21,58,81,202],"therapies":[22],"alleviates":[23],"and":[25,37,104,112,153,180],"provides":[26],"clinical":[27,64,194],"benefits":[28],"the":[30,46,93,140],"control":[31],"SEA.":[33],"Curiously,":[34],"a":[35,183,193,205],"stable":[36],"interindividually":[38],"consistent":[39],"population":[40],"residual":[42,54,84,171,208],"eosinophils":[43,55,86,98,126,138,172,209],"persists":[44],"blood":[47,85,141],"following":[48,87,113],"mepolizumab":[50,148,174],"treatment.":[51,158],"Whether":[52],"these":[53,196],"possess":[56],"particular":[57],"activity":[59],"unknown":[61],"but":[62,227],"relevance":[65],"predicting":[67],"long-term":[68,200],"effects":[69],"IL5":[71,88,161,201,220],"neutralization.":[72],"In":[73],"this":[74],"study,":[75],"we":[76,91,217],"aimed":[77],"at":[78,107],"identifying":[79],"potential":[80],"alterations":[82],"deprivation.":[89],"Therefore,":[90],"compared":[92,149],"gene":[94],"expression":[95],"program":[96],"IL5-depleted":[100],"or":[101,131,177],"IL5-replete":[102],"human":[103],"murine":[105],"hosts,":[106],"steady":[108],"state":[109],"vivo":[111],"stimulation":[114],"by":[115,122,136],"eosinophil-activating":[116],"alarmin":[117],"IL33":[118],"ex":[119],"vivo.":[120],"First,":[121],"comparing":[123,137],"bone":[124],"marrow":[125],"mice":[128],"genetically":[129],"deficient":[130],"not":[132,164,222],"for":[133],"IL5.":[134],"Second,":[135],"patients":[143,155,176],"SEA":[145],"treated":[146,175],"to":[150,190],"healthy":[151,214],"controls":[152],"matched":[154],"receiving":[156],"omalizumab":[157],"Restriction":[159],"availability":[162],"did":[163],"elicit":[165],"any":[166],"demonstrable":[167],"transcriptional":[168],"response":[169,189],"from":[173],"IL5-deficient":[178],"mice,":[179],"only":[181],"affected":[182],"handful":[184],"genes":[186],"their":[188,229],"IL33.":[191],"From":[192],"perspective,":[195],"results":[197],"suggest":[198,218],"that":[199,210,219],"therapy":[203],"spares":[204],"pool":[206],"resemble":[211],"those":[212],"controls.":[215],"Fundamentally,":[216],"does":[221],"impact":[223],"on":[224],"eosinophil":[225],"development":[226],"rather":[228],"expansion.":[230]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3214737010","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2021-12-06T00:00:00"}
